UBS Oncology Impact Fund L.P. - 10%+ Owner at Tcr2 Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
TCRR
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by UBS Oncology Impact Fund L.P. since 9/12/2023

Holdings reported by UBS Oncology Impact Fund L.P. for Tcr2 Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $1.72 Jun 1, 2023 Direct

Transactions reported by UBS Oncology Impact Fund L.P. for Tcr2 Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.